Drug intelligence / Profile preview

PluraStem

Development stage
Preclinical
Lead developer
Escape Therapeutics
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intramuscular, Intravenous
01

Overview

PluraStem is a preclinical-stage platform technology developed by Escape Therapeutics that utilizes a proprietary immune tolerance (IT) platform to create universal pluripotent embryonic stem cells (ESCs). These cells are engineered to express a tolerogenic molecule on their extracellular membranes, which confers immune protection and allows the cells to evade immune rejection by the recipient's immune system. The platform is designed to enable the development of off-the-shelf, ESC-derived cell replacement therapies that can be administered to patients of any HLA type without the need for HLA matching or adjunctive immunosuppression. PluraStem serves as the foundational technology for deriving various specialized cell types, such as beta cells or fibroblasts, for downstream therapeutic applications.

Brand names
PluraStem
Other names
Universal embryonic stem cellsPluraStem platform

Beyond the preview

Go deeper on PluraStem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PluraStem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call